<?xml version="1.0" encoding="UTF-8"?>
<p class="p">Treating wound infections produced by multidrug-resistant bacteria is a major task owing to the incapability of conventional antibiotics to treat such infections [
 <xref rid="B145-molecules-23-02392" ref-type="bibr" class="xref">145</xref>]. NPs are considered as promising replacements to habitually applied antibiotics, as they alone demonstrated bactericidal activity against a big number of pathogens, are capable of diminishing side effects of medications and do not produce microbial resistance [
 <xref rid="B27-molecules-23-02392" ref-type="bibr" class="xref">27</xref>].
</p>
